Back

Surging COVID-19 in Bangladesh driven by B.1.351 variant

Brum, E.; Saha, S.; Sania, A.; Tanmoy, A. M.; Hooda, Y.; Tanni, A.; Goswami, S.; Sium, S. M. A.; Sajib, M. S. I.; Malaker, R.; Islam, S.; Sarker, N.; Saha, S. K.; Chowdhury, S.; Haddou, Y.; Ferguson, E. A.; Kundegorski, M.; Purno, N.; Tasneem, M.; Arifeen, S. E.; Alamgir, A. S. M.; Chowdhury, A.; Hampson, K.

2021-04-29 public and global health
10.1101/2021.04.27.21255706 medRxiv
Show abstract

A dramatic resurgence of COVID-19 cases and deaths in Bangladesh in March 2021 coincided with the SARS-CoV-2 B.1.351 (501Y.V2) variant of concern rapidly becoming the dominant circulating variant. Concurrently, increasing numbers of reinfections have been detected and the effective Reproductive number, Rt, has doubled, despite high levels of prior infection in Dhaka city. These data support the prediction that acquired immunity from past infection provides reduced protection against B.1.351, and highlights the major public health concern posed by immune escape variants, especially in populations where vaccination coverage remains low.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.